What is the rate of traumatic intracranial hemorrhage from a ground-level fall in patients taking antithrombotic therapy?

BEEM Bottom Line

Why is this study important?

Head injuries (HI) are common among patients taking antiplatelet or anticoagulant medications. Since 2009, newer antithrombotic agents have been introduced, which together with the “silver tsunami,” have lead to an increasing number of emergency department (ED) patients with HI taking newer, albeit possibly safer, antithrombotics. As a result, little is known about the incidence of traumatic intracranial hemorrhage (tICH) from a ground-level fall.

Which, if any, threats to validity are most likely to have an impact on the results and how?

Thank you for your interest in the BEEM Journal!

To read the rest of this article or to access the entire collection of BEEM Critical Appraisals, please purchase a subscription at the link below.

If you would like a pre-view, click here to view some sample articles

Premium Content Available Through Subscription

BEEM is a knowledge translation project which aims to extract the most recent, EM relevant, and valid evidence from the volumes of available medical research and deliver it to EM practitioners in an easily consumable format to help guide their clinical practice. This valuable distilled information provided by BEEM is available through BEEM's accredited CME courses or through our online journal.

A BEEM Journal Subscription will provide you with unlimited access to our entire collection of Critical Appraisals for 1 year.